Glaxosmithkline

  • GlaxoSmithKline aims to market world's first malaria vaccine 08-10-2013 02:34 PM

    British drugmaker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children. The vaccine known as RTS,S was found, after 18 months of follow-up, to have almost halved the number of malaria...
  • GSK faces Q4 profit wipe-out on $3 billion legal hit 18-01-2011 06:05 PM

    London: GlaxoSmithKline will record a legal charge of 2.2 billion pounds ($3.4 billion) for the fourth quarter, effectively wiping out its profit, as it settles further claims related to Avandia and sales practices. The charge equates to an after-tax cost of 1.8 billion pounds, more than the 1.45 billion the...
  • GSK offers UK rebate against Pfizer drug 24-12-2010 10:25 AM

    London: Britain's state-run health service will get a partial rebate from GlaxoSmithKline if the company's new kidney cancer drug Votrient does not match up to a rival medicine in a head-to-head clinical trial. The unusual deal, the first of its kind, hints at the type of complex arrangements that could...
  • Diabetes drug may be bad for heart: Report 21-02-2010 06:43 PM

    An internal report by the US Food and Drug Administration has said that common diabetes drug Rosiglitazone comes with a risk of heart attacks. Sold by GSK under the name Avandia, the drug reportedly causes fluid retention. A US Senate report has alleged that drugmaker GlaxoSmithKline knew of the risks....
  • Business pays for Telangana row 11-12-2009 07:49 PM

    ...